Product Code: GVR-1-68038-352-2
Sepsis Diagnostics Market Growth & Trends:
The global sepsis diagnostics market size is expected to reach USD 1.82 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.0% from 2024 to 2030. The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected to propel market growth over the forecast period. Sepsis is a bloodstream disease that occurs as a result of a response to pathogenic microorganisms present in the blood. Patients suffering from this disease experience severe inflammation, which leads to prolonged hospitalization.
According to the WHO, around 30 million people are estimated to be affected by this disease every year. The NCBI stated that the largest number of this condition have been observed in the youngest and oldest age groups. Thus, there is a rising need for the early diagnosis of this disease. The WHO reported that every year, 1.2 million children and 3 million newborns are affected by this disease across the world. This has further boosted the demand for its diagnostic tools for quick results and improved patient outcomes. Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions for sepsis are expected to facilitate market growth over the forecast period.
In May 2018, T2 Biosystems, Inc., a U.S.-based emerging diagnostic solutions company, received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens. The COVID-19 pandemic affected the growth of diagnostics products for sepsis in a moderately positive way. The worldwide spread of Coronavirus and the arising instances of sepsis among COVID-19 patients are probably going to expand the interest for fast detection, speeding up the use of instruments, reagents, and assay kits for recognition of sepsis. Pandemic-induced lockdown and other restrictions made individuals delay going through wellbeing checkups, influencing the number of tests performed and reagent deals.
The pandemic has featured the risk upon elders, who are more defenseless to complications, including intense respiratory distress condition, typically because of pneumonia, which builds the risk of creating sepsis. This has created a need for the early detection of sepsis among patients with COVID-19. Symptoms of sepsis, such as multiorgan injuries, develop in around 2.0 to 5.0% of COVID-19 cases 8 to 10 days post-hospitalization, based on the estimates of the Global Sepsis Alliance. To manage this situation, the Biomedical Advanced Research and Development Authority, in May 2020, extended its partnership with Beckman Coulter for the development of a digital algorithm to detect sepsis in patients with COVID-19.
Sepsis Diagnostics Market Report Highlights:
- Based on product type, blood culture media dominated the market in 2023 with a revenue share of more than 38.9%, as blood culture is considered the most cost-effective and convenient testing mode.
- The microbiology technology segment dominated the market in 2023 and held the largest share of more than 48.9% of the overall revenue. Microbial culture is the primary and gold standard method for detecting infectious disease-causing organisms in laboratory settings.
- Bacterial segment held the largest revenue share of 86.0% of the market in 2023. It is anticipated to lead over the forecast period due to the rise in cases of bacterial sepsis, higher occurrence of hospital-transmitted infections, and rising number of surgical procedures conducted.
- The conventional diagnostics segment held the largest revenue share of 57.6% of the market in 2023.
- The laboratory testing type segment dominated the market in 2023 with a share of 82.6%. Advancements in laboratory testing have made it easier and faster to detect sepsis, leading to better outcomes for patients.
- North America dominated the market in 2023 and held the largest revenue share of more than 44.1%. High incidence of sepsis and infectious diseases is expected to fuel demand for novel diagnostic solutions.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation And Scope
- 1.1 Market Definitions
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach: Commodity Flow Approach
- 1.7 Research Assumptions
- 1.8 List Of Secondary Sources
- 1.9 List Of Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.10.3 Objective 3
- 1.10.4 Objective 4
Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Product And Technology Snapshot
- 2.3 Pathogen And Testing Type Snapshot
- 2.4 Method And End-user Snapshot
- 2.5 Competitive Landscape Snapshot
Chapter 3 Sepsis Diagnostics Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Related/ancillary Market Outlook
- 3.2 Market Dynamics
- 3.2.1 Market Driver Impact Analysis
- 3.2.1.1 Increase In Prevalence Of Sepsis
- 3.2.1.2 Rise In Incidence Of Hospital-acquired Infections
- 3.2.1.3 Increase In The Number Of Pneumonia Cases
- 3.2.1.4 Approval And Launch Of Advanced Sepsis Diagnostic System
- 3.2.2 Market Restraint Analysis
- 3.2.2.1 High Cost Of Automated Diagnostic Instruments
- 3.2.2.2 Lack Of Awareness About Sepsis
- 3.2.3 Industry Challenges
- 3.2.3.1 Scientific And Clinical Challenges Associated With Sepsis
- 3.3 Sepsis Diagnostics: Market Analysis Tools
- 3.3.1 Porter's Analysis
- 3.3.2 Sepsis Diagnostics - Macroeconomic Analysis
Chapter 4 Sepsis Diagnostics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
- 4.1 Sepsis Diagnostics Market: Product Movement Analysis
- 4.2 Sepsis Diagnostics Market Estimates & Forecast, By Product (USD Million)
- 4.2.1 Instrument
- 4.2.2 Blood Culture Media
- 4.2.3 Assay Kits And Reagents
- 4.2.4 Software
Chapter 5 Sepsis Diagnostics Market: Segment Analysis, By Technology, 2018 - 2030 (USD Million)
- 5.1 Sepsis Diagnostics Market: Technology Movement Analysis
- 5.2 Sepsis Diagnostics Market Estimates & Forecast, By Technology (USD Million)
- 5.2.1 Microbiology
- 5.2.2 Molecular Diagnostics
- 5.2.2.1 Polymerase Chain Reaction (Pcr)
- 5.2.2.2 Dna Microarrays
- 5.2.2.3 Syndromic Panel Testing
- 5.2.2.4 Others
- 5.2.3 Immunoassays
- 5.2.4 Flow Cytometry
- 5.2.5 Others
Chapter 6 Sepsis Diagnostics Market: Segment Analysis, By Pathogen, 2018 - 2030 (USD Million)
- 6.1 Sepsis Diagnostics Market: Pathogen Movement Analysis
- 6.2 Sepsis Diagnostics Market Estimates & Forecast, By Pathogen (USD Million)
- 6.2.1 Bacterial Sepsis
- 6.2.1.1 Gram-positive Bacteria
- 6.2.1.2 Gram-negative Bacteria
- 6.2.2 Fungal Sepsis
- 6.2.3 Viral Sepsis And Others
Chapter 7 Sepsis Diagnostics Market: Segment Analysis, By Testing Type, 2018 - 2030 (USD Million)
- 7.1 Sepsis Diagnostics Market: Testing Type Movement Analysis
- 7.2 Sepsis Diagnostics Market Estimates & Forecast, By Testing Type (USD Million)
- 7.2.1 Laboratory Testing
- 7.2.2 Point-of-care Testing
Chapter 8 Sepsis Diagnostics Market: Segment Analysis, By Method, 2018 - 2030 (USD Million)
- 8.1 Sepsis Diagnostics Market: Method Movement Analysis
- 8.2 Sepsis Diagnostics Market Estimates & Forecast, By Method (USD Million)
- 8.2.1 Automated Diagnostics
- 8.2.2 Conventional Diagnostics
Chapter 9 Sepsis Diagnostics Market: Segment Analysis, By End-user, 2018 - 2030 (USD Million)
- 9.1 Sepsis Diagnostics Market: End-user Movement Analysis
- 9.2 Sepsis Diagnostics Market Estimates & Forecast, By End-user (USD Million)
- 9.2.1 Hospitals & Clinics
- 9.2.2 Pathology & Reference Laboratories
- 9.2.3 Research Institutes And Others
Chapter 10 Sepsis Diagnostic Market: Regional Estimates And Trend Analysis, By Product, By Technology, By Pathogen, By Testing Type, By Method, & By End-user
- 10.1 Sepsis Diagnostic Market: Regional Outlook
- 10.2 North America
- 10.2.1 North America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.2.1.1 Regulatory Framework
- 10.2.1.2 Reimbursement Scenario
- 10.2.2 U.s.
- 10.2.2.1 Key Country Dynamics
- 10.2.2.2 U.s. Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.2.2.3 Market & Competitive Scenario
- 10.2.3 Canada
- 10.2.3.1 Key Country Dynamics
- 10.2.3.2 Canada Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.2.3.3 Market And Competitive Scenario
- 10.3 Europe
- 10.3.1 Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3.1.1 Regulatory Framework
- 10.3.1.2 Reimbursement Scenario
- 10.3.2 Uk
- 10.3.2.1 Key Country Dynamics
- 10.3.2.2 Uk Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3.2.3 Market & Competitive Scenario
- 10.3.3 Germany
- 10.3.3.1 Key Country Dynamics
- 10.3.3.2 Germany Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3.3.3 Market & Competitive Scenario
- 10.3.4 France
- 10.3.4.1 Key Country Dynamics
- 10.3.4.2 France Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3.4.3 Market & Competitive Scenario
- 10.3.5 Spain
- 10.3.5.1 Key Country Dynamics
- 10.3.5.2 Spain Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3.5.3 Market & Competitive Scenario
- 10.3.6 Italy
- 10.3.6.1 Key Country Dynamics
- 10.3.6.2 Italy Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3.6.3 Market & Competitive Scenario
- 10.3.7 Denmark
- 10.3.7.1 Key Country Dynamics
- 10.3.7.2 Denmark Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3.7.3 Market & Competitive Scenario
- 10.3.8 Sweden
- 10.3.8.1 Key Country Dynamics
- 10.3.8.2 Sweden Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3.8.3 Market & Competitive Scenario
- 10.3.9 Norway
- 10.3.9.1 Key Country Dynamics
- 10.3.9.2 Norway Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3.9.3 Market & Competitive Scenario
- 10.3.10 Russia
- 10.3.10.1 Key Country Dynamics
- 10.3.10.2 Russia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3.10.3 Market & Competitive Scenario
- 10.3.10.4 Rest Of Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.4 Asia Pacific
- 10.4.1 Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.4.1.1 Regulatory Framework
- 10.4.1.2 Reimbursement Scenario
- 10.4.2 Japan
- 10.4.2.1 Key Country Dynamics
- 10.4.2.2 Japan Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.4.2.3 Market And Competitive Scenario
- 10.4.3 China
- 10.4.3.1 Key Country Dynamics
- 10.4.3.2 China Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.4.3.3 Market And Competitive Scenario
- 10.4.4 India
- 10.4.4.1 Key Country Dynamics
- 10.4.4.2 India Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.4.4.3 Market And Competitive Scenario
- 10.4.5 Australia
- 10.4.5.1 Key Country Dynamics
- 10.4.5.2 Australia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.4.5.3 Market And Competitive Scenario
- 10.4.6 Thailand
- 10.4.6.1 Key Country Dynamics
- 10.4.6.2 Thailand Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.4.6.3 Market And Competitive Scenario
- 10.4.7 South Korea
- 10.4.7.1 Key Country Dynamics
- 10.4.7.2 South Korea Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.4.7.3 Market And Competitive Scenario
- 10.4.8 Singapore
- 10.4.8.1 Key Country Dynamics
- 10.4.8.2 Singapore Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.4.8.3 Market And Competitive Scenario
- 10.4.8.4 Rest Of Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.5 Latin America
- 10.5.1 Latin America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.5.1.1 Regulatory Framework
- 10.5.1.2 Reimbursement Scenario
- 10.5.2 Brazil
- 10.5.2.1 Key Country Dynamics
- 10.5.2.2 Brazil Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.5.2.3 Market And Competitive Scenario
- 10.5.3 Mexico
- 10.5.3.1 Key Country Dynamics
- 10.5.3.2 Mexico Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.5.3.3 Market And Competitive Scenario
- 10.5.4 Argentina
- 10.5.4.1 Key Country Dynamics
- 10.5.4.2 Argentina Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.5.4.3 Market And Competitive Scenario
- 10.5.4.4 Rest Of Latam Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.6 MEA
- 10.6.1 MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.6.1.1 Regulatory Framework
- 10.6.1.2 Reimbursement Scenario
- 10.6.2 South Africa
- 10.6.2.1 Key Country Dynamics
- 10.6.2.2 South Africa Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.6.2.3 Market And Competitive Scenario
- 10.6.3 Saudi Arabia
- 10.6.3.1 Key Country Dynamics
- 10.6.3.2 Saudi Arabia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.6.3.3 Market And Competitive Scenario
- 10.6.4 UAE
- 10.6.4.1 Key Country Dynamics
- 10.6.4.2 UAE Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.6.4.3 Competitive Scenario
- 10.6.5 Kuwait
- 10.6.5.1 Key Country Dynamics
- 10.6.5.2 Kuwait Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.6.5.3 Market And Competitive Scenario
- 10.6.5.4 Rest Of MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 11 Competitive Landscape
- 11.1 Company Categorization
- 11.2 Company Market Positioning
- 11.2.1 Market Leaders
- 11.2.1.1 Sepsis Diagnostics Market Share Analysis, 2023
- 11.3 Company Profiles
- 11.3 Company Profiles
- 11.3.1 Biomerieux Sa
- 11.3.1.1 Company Overview
- 11.3.1.2 Financial Performance
- 11.3.1.3 Product Benchmarking
- 11.3.1.4 Strategic Initiatives
- 11.3.2 Becton, Dickinson And Company (Bd)
- 11.3.2.1 Company Overview
- 11.3.2.2 Financial Performance
- 11.3.2.3 Product Benchmarking
- 11.3.2.4 Strategic Initiatives
- 11.3.3 Thermo Fisher Scientific, Inc.
- 11.3.3.1 Company Overview
- 11.3.3.2 Financial Performance
- 11.3.3.3 Product Benchmarking
- 11.3.3.4 Strategic Initiatives
- 11.3.4 F. Hoffmann-la Roche
- 11.3.4.1 Company Overview
- 11.3.4.2 Financial Performance
- 11.3.4.3 Product Benchmarking
- 11.3.4.4 Strategic Initiatives
- 11.3.5 Luminex Corporation
- 11.3.5.1 Company Overview
- 11.3.5.2 Financial Performance
- 11.3.5.3 Product Benchmarking
- 11.3.5.4 Strategic Initiatives
- 11.3.6 Danaher (Beckman Coulter, Inc.)
- 11.3.6.1 Company Overview
- 11.3.6.2 Financial Performance
- 11.3.6.3 Product Benchmarking
- 11.3.6.4 Strategic Initiatives
- 11.3.7 Bruker Corporation
- 11.3.7.1 Company Overview
- 11.3.7.2 Financial Performance
- 11.3.7.3 Product Benchmarking
- 11.3.7.4 Strategic Initiatives
- 11.3.8 Cepheid
- 11.3.8.1 Company Overview
- 11.3.8.2 Financial Performance
- 11.3.8.3 Product Benchmarking
- 11.3.8.4 Strategic Initiatives
- 11.3.9 Koninklijke Philips N.v.
- 11.3.9.1 Company Overview
- 11.3.9.2 Financial Performance
- 11.3.9.3 Product Benchmarking
- 11.3.9.4 Strategic Initiatives
- 11.3.10 Immunexpress, Inc.
- 11.3.10.1 Company Overview
- 11.3.10.2 Financial Performance
- 11.3.10.3 Product Benchmarking
- 11.3.10.4 Strategic Initiatives